Susquehanna International Group
ALXA

Susquehanna International Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Susquehanna International Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,000
Closed -$52K – 10403
2014
Q4 		$52K Sell
35,000
-11,500
-25% -$20.5K ﹤0.01% 9361
2014
Q3 		$108K Buy
46,500
+6,700
+17% +$25.6K ﹤0.01% 9046
2014
Q2 		$182K Sell
39,800
-53,900
-58% -$233K ﹤0.01% 9142
2014
Q1 		$415K Buy
93,700
+55,600
+146% +$285K ﹤0.01% 7045
2013
Q4 		$180K Sell
38,100
-97,100
-72% -$476K ﹤0.01% 8347
2013
Q3 		$692K Buy
135,200
+53,300
+65% +$251K ﹤0.01% 5932
2013
Q2 		$355K Buy
+81,900
New +$371K ﹤0.01% 6549

Susquehanna International Group's ALXA Position: Q2 2016 in Review

Susquehanna International Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 26,110 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in ALXA in Q4 2013 and held it in 6 quarters. The position peaked at $115K in Q4 2013. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Susquehanna International Group reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Susquehanna International Group sold 26,110 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $13K.
  • Susquehanna International Group first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 6 quarters.
  • Susquehanna International Group's Alexza Pharmaceuticals Inc position peaked at $115K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.